SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-195003
Filing Date
2018-06-18
Accepted
2018-06-18 07:40:06
Documents
3
Period of Report
2018-06-12
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d206889d8k.htm 8-K 17492
2 EX-99.1 d206889dex991.htm EX-99.1 10546
3 GRAPHIC g2068891img.jpg GRAPHIC 8362
  Complete submission text file 0001193125-18-195003.txt   41005
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33038 | Film No.: 18903592
SIC: 2834 Pharmaceutical Preparations